ERIN GIDDENS: Open Payments
NPI 1417608993 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 13 payments from 10 companies in 2025. Trend: 2023 $297 · 2024 $364 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 2 | $38 |
| Exeltis, USA Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
| ABBVIE INC. | 1 | $24 |
| American Regent | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Organon LLC | 1 | $20 |
| CooperSurgical, Inc. | 1 | $20 |
| MIMEDX Group, Inc. | 1 | $14 |
Products named: ZURZUVAE, SLYND, MYFEMBREE, Veozah, LILETTA, INJECTAFER, APTIMA, NEXPLANON.
Industry payments across NJ — which companies pay providers there.
